Anti-tuberculosis activity of some N-pentopyranosylamines.
With the advent of multidrug-resistant Mycobacterium tuberculosis, new effective drugs are rapidly needed. Thirty-two derivatives of some N-pentopyranosylamines were prepared and tested under the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) program. This communication is presenting their antituberculosis activity in the primary screen.